Efficacy and Safety of Semaglutide for the Management of Obese Patients With Type 2 Diabetes and Chronic Heart Failure in Real-World Clinical Practice

Autor: Luis M. Pérez-Belmonte, Jaime Sanz-Cánovas, María D. García de Lucas, Michele Ricci, Beatriz Avilés-Bueno, Lidia Cobos-Palacios, Miguel A. Pérez-Velasco, Almudena López-Sampalo, M. Rosa Bernal-López, Sergio Jansen-Chaparro, José P. Miramontes-González, Ricardo Gómez-Huelgas

Publikováno v: Frontiers in Endocrinology, Vol 13 (2022)

BackgroundThe impact of glucagon-like peptide-1 receptor agonists on patients with heart failure has not been fully described. Our main objective was to evaluate the safety and clinical and glycemic efficacy of once-weekly semaglutide in obese patien

Externí odkaz: https://doaj.org/article/80e2d36af32042089b464947c5cd246c

Comprehensive management of risk factors in peripheral vascular disease. Expert consensus

Autor: Pilar Caridad Morata Barrado, Carlos Guijarro Herraiz, Jorge Jesús Martín Cañuelo, J.F. Merino-Torres, Cristina Tejera Pérez, María Ángeles Martínez López, Teresa Rama Martínez, Sergio Cinza-Sanjurjo, Mª Dolores Aicart Bort, C. Brotons, Vicente Pascual Fuster, Emilio Ortega, Tomás Ripoll Vera, Carmen Peinado Adiego, Alberto Cordero, Carlos Jericó Alba, Luis Castilla-Guerra, Francisco Valls-Roca, Pablo Antonio Toledo Frías, Rosa María Sánchez-Hernández, Antonio Pérez Pérez, Ángel Brea Hernando, Juan Girbés Borrás, Miguel Ángel Prieto Díaz, J.M. Mostaza, María Soledad Navas de Solís, Elisa Velasco Valdazo, Estíbaliz Jarauta Simón, Juan Carlos Ferrer García, José Manuel Ruiz Palomar, Francisco M. Morales-Pérez, Julio Sánchez Álvarez, Javier de Juan Bagudá, Núria Muñoz Rivas, Elías Delgado, Manuel Frías Vargas, Ovidio Muñiz Grijalvo, Esther Doiz Artázcoz, Pedro Valdivielso, Adriana Saltijeral Cerezo, Rebeca Reyes García, Manuel Rodríguez Piñero, Beatriz Jiménez Muñoz, Luis Leiva Hernando, Enrique Rodilla Sala, Alfonso Barquilla García, Jose Daniel Mosquera Lozano, Carlos Santos Altozano, Antonio Miguel Hernández Martínez, Alejandro Berenguel Senén, Manuel Gargallo Fernández, María Gloria Cánovas Molina, Julio Antonio Carbayo Herencia, Ignacio Párraga Martínez, Elena Iborra Ortega, Aurora García Lerín, Vicente Ignacio Arrarte Esteban, Vivencio Barrios, Jose Polo García, Manuel Antonio Botana López, Ruth Sánchez Ortiga, Manuel Suárez Tembra, Miguel Brito Banfiel, Ángel Carlos Matía Cubillo, José María Cepeda Rodrigo, Daniel Escribano Pardo, P. Beato, M. Comellas, Inés Gil Gil, R. Campuzano, Martín Ruiz Ortiz, Víctor Rodríguez Sáenz de Buruaga, Agustín Blanco Echevarría, Rosario Lorente Calvo, José Manuel Comas Samper, Sergio Hevia, Natalia de la Fuente, Juan Cosin Sales, Rafael Vidal-Pérez, Virginia Bellido Castañeda, N. Plana, Amelia Carro, Carlos Lahoz, Magdalena León Mazorra, Sergio Martínez Hervas, Maria Seoane Vicente, Melina Vega de Ceniga, M. Antonia Pérez Lázaro, Sergio Jansen Chaparro, Antonio Ruiz García, Isabel Ayala Vigueras, Miren Morillas Bueno, Esther Merino Lanza, Andrés Galarza Tapia, Marta Casañas Martínez, Daiana Ibarretxe Gerediaga, María Durán Martínez, José Antonio Rubio, Óscar Moreno-Pérez, Andrés García León, Luis Estallo Laliena, Eduardo Carrasco Carrasco, Vicente Pallarés-Carratalá, Alberto Zamora Cervantes, Javier Escalada, Juan Carlos Obaya Rebollar, Mercedes Guerra Requena, José Antonio Quindimil Vázquez, Pedro J. Pinés Corrales, Carlos Escobar Cervantes, Lisardo García-Martín, Albert Clarà, Jose María Fernández Rodriguez-Lacin, Miguel Turégano Yedro, Francisco Javier Félix Redondo, Luis Masmiquel, Jacinto Fernández Pardo, Laura Calsina Juscafresa, María Eugenia López Valverde, Eva María Pereira López, Fátima Almagro Múgica, Agustín Medina Falcón

Publikováno v: Revista Clínica Española (English Edition). 222:82-90

There is currently a degree of divergence among the main clinical practice guidelines on the management of risk factors for peripheral arterial disease (PAD). This project aims to gain understanding of the management of PAD risk factors in clinical p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bee6670dc2c43df3c36b26d32d1b7df6
https://doi.org/10.1016/j.rceng.2020.11.011

Management of older hospitalized patients with type 2 diabetes using linagliptin: Lina-Older Study

Autor: Michele Ricci, M. Rosa Bernal-Lopez, María D. López-Carmona, J.P. Lara, Miguel Ángel Barbancho, Sergio Jansen-Chaparro, Julio Osuna-Sánchez, Luis M. Pérez-Belmonte, Ricardo Gómez-Huelgas, Mercedes Millán-Gómez

Publikováno v: Panminerva medica.

Older patients managed with intensive antidiabetic therapy are more likely to be harmed. Our study's primary endpoint was to analyze the safety and efficacy of linagliptin in combination with basal insulin versus basal-bolus insulin in patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a5807dde2d9c566081e602870777814
https://pubmed.ncbi.nlm.nih.gov/33880897

Diabetes tipo 2 en paciente anciano

Autor: Almudena López-Sampalo, Lidia Cobos-Palacios, Clara Costo-Muriel, Sergio Jansen-Chaparro, Ricardo Gómez-Huelgas

Publikováno v: Revista Española de Casos Clínicos en Medicina Interna. 2018:17-18

La diabetes mellitus (DM) es la quinta enfermedad más frecuente en el anciano, tras la artrosis, la hipertensión arterial, las cataratas y las enfermedades cardiovasculares. El número de ancianos con DM está creciendo por el aumento de la expecta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1532c8f3daf4dc0262ac850c9afae2ea
https://doi.org/10.32818/reccmi.a3s1a8

Why not use the HbA1c as a criterion of dysglycemia in the new definition of the metabolic syndrome? Impact of the new criteria in the prevalence of the metabolic syndrome in a Mediterranean urban population from Southern Europe (IMAP study. Multidisciplinary intervention in primary care)

Autor: Francisco J. Tinahones, Aurora Villalobos-Sanchez, Antonio J Baca-Osorio, Ricardo Gómez-Huelgas, Jose Mancera-Romero, Sergio Jansen-Chaparro, M. Rosa Bernal-Lopez, María D. López-Carmona

Publikováno v: Diabetes Research and Clinical Practice. 93:e57-e60

We analysed the prevalence of metabolic syndrome (MS) of the new diagnostic criteria and the HbA1c to diagnose dysglycemia. We studied 2006 adults without cardiovascular disease or diabetes. The use of the new criteria and the HbA1c resulted in an in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41ac0a65edcff1276dc7beb697a431bc
https://doi.org/10.1016/j.diabres.2011.02.024